Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacological perturbation reveals deficits in D2 receptor responses in Thap1 null mice

Annals of Clinical and Translational Neurology(2021)10.1002/acn3.51481Source: DataRank Database

Pharmacological perturbation reveals deficits in D2 receptor responses in Thap1 null mice is a research paper published in Annals of Clinical and Translational Neurology (2021). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 0.19)OA: goldTopics (39)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Morgan M. Pooler,Parth Shah ORCID,Alessandro Didonna ORCID,Puneet Opal ORCID,Natalie M. Frederick

Live enrichment

PubMed:34802187 OpenAlex:https://openalex.org/W3215640522

National Institutes of Health

Grant: 1R01NS062051

National Institutes of Health

Grant: 1R01NS082351

National Institutes of Health

Grant: R56NS108639

National Institutes of Health

Grant: U01NS104326

National Institutes of Health

Grant: R56NS121112

Conrad N. Hilton Foundation

Grant: 17323

National Multiple Sclerosis Society

Grant: RG‐1901‐33219

Fondazione Italiana Sclerosi Multipla

Grant: 2014/B/1

Fondazione Italiana Sclerosi Multipla

Grant: 2017/B/3

National Multiple Sclerosis Society

Grant: RG-1901-33219

NINDS NIH HHS

Grant: R01 NS082351

NINDS NIH HHS

Grant: R01 NS062051

International Progressive MS Alliance

Grant: PA-2001-36176

National Ataxia Foundation

Biohaven Pharmaceuticals

FWCI

0.19

Citation Percentile

0.4%

Citation Trend

2022

2023

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1002/acn3.51481

GOLDhttps://doi.org/10.1002/acn3.51481

publisherhttps://doi.org/10.1002/acn3.51481

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51481

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/acn3.51481

Fields of Study

Genetic Neurodegenerative DiseasesNeurological disorders and treatmentsIon channel regulation and functionMedicineBiologyAnimalsDNA-Binding ProteinsDisease Models, AnimalDopamine AgonistsDopamine AntagonistsDystonia Musculorum DeformansMiceMice, Inbred C57BLMice, KnockoutReceptors, Dopamine D1Receptors, Dopamine D2Dystonia 6, torsion

MeSH Terms

AnimalsDisease Models, AnimalDNA-Binding ProteinsDystonia Musculorum DeformansMice, Inbred C57BLReceptors, Dopamine D1Receptors, Dopamine D2Mice, KnockoutDopamine AgonistsDopamine AntagonistsMice

Keywords

DopaminergicReceptorTranscription factorGeneBiologyMedicineGeneticsPharmacologyNeuroscienceInternal medicineDopamine

Sustainable Development Goals

SDG 0: Good health and well-being